ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 121 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $191,318 | -3.0% | 57,800 | -4.1% | 0.02% | -14.3% |
Q1 2024 | $197,181 | -4.0% | 60,300 | +3.1% | 0.02% | -19.2% |
Q4 2023 | $205,335 | -31.4% | 58,500 | +19.4% | 0.03% | -36.6% |
Q3 2023 | $299,280 | -26.1% | 48,982 | +1.4% | 0.04% | -24.1% |
Q2 2023 | $405,128 | -39.5% | 48,287 | -28.3% | 0.05% | -44.3% |
Q1 2023 | $669,203 | +53.1% | 67,392 | +7.3% | 0.10% | +115.6% |
Q4 2022 | $437,137 | +37.9% | 62,807 | +6.0% | 0.04% | -33.8% |
Q3 2022 | $317,000 | +32.6% | 59,277 | -1.0% | 0.07% | +223.8% |
Q2 2022 | $239,000 | -5.9% | 59,875 | +4.8% | 0.02% | -54.3% |
Q1 2022 | $254,000 | +26.4% | 57,125 | +13.5% | 0.05% | +31.4% |
Q4 2021 | $201,000 | -45.8% | 50,325 | +19.3% | 0.04% | -47.0% |
Q3 2021 | $371,000 | +20.1% | 42,200 | +54.7% | 0.07% | +15.8% |
Q2 2021 | $309,000 | +1.0% | 27,275 | -27.0% | 0.06% | +103.6% |
Q1 2021 | $306,000 | +63.6% | 37,355 | +36.8% | 0.03% | -17.6% |
Q4 2020 | $187,000 | – | 27,315 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,155,300 | $4,621,000 | 2.77% |
Knoll Capital Management, LLC | 759,405 | $3,038,000 | 1.67% |
ACUTA CAPITAL PARTNERS, LLC | 500,000 | $2,000,000 | 0.84% |
Perceptive Advisors | 19,807,758 | $79,232,000 | 0.61% |
Mesirow Financial Investment Management, Inc. | 48,711 | $195,000 | 0.56% |
Ghost Tree Capital, LLC | 300,000 | $1,200,000 | 0.43% |
Stonepine Capital Management, LLC | 200,000 | $800,000 | 0.37% |
APOGEM CAPITAL LLC | 86,730 | $347,000 | 0.23% |
JOHNSON & JOHNSON | 394,834 | $1,579,000 | 0.18% |
Affinity Asset Advisors, LLC | 100,759 | $403,000 | 0.15% |